ARTICLE | Clinical News
Nerixia neridronic acid regulatory update
April 21, 2014 7:00 AM UTC
Abiogen and Clinigen Group Ltd. (Burton-on-Trent, U.K.) announced the start of a named-patient program in the EU to provide access to Nerixia neridronic acid to treat osteogenesis imperfecta. Clinigen...